Recent changes
Jump to navigation
Jump to search
Track the most recent changes to the wiki on this page.
List of abbreviations:
- N
- This edit created a new page (also see list of new pages)
- m
- This is a minor edit
- b
- This edit was performed by a bot
- (±123)
- The page size changed by this number of bytes
2 May 2024
|
|
01:36 | Main Page 2 changes history -38 [Warner-admin (2×)] | |||
|
|
01:36 (cur | prev) -2 Warner-admin talk contribs | ||||
|
|
01:34 (cur | prev) -36 Warner-admin talk contribs | ||||
|
|
m 01:26 | Immunotherapy toxicity management 3 changes history -2,557 [Jwarner (3×)] | |||
| m |
|
01:26 (cur | prev) -14 Jwarner talk contribs | |||
| m |
|
01:26 (cur | prev) +15 Jwarner talk contribs →Guidelines | |||
| m |
|
01:24 (cur | prev) -2,558 Jwarner talk contribs →Guidelines | |||
|
|
N 01:04 | Category:Guideline pages 2 changes history +144 [Jwarner (2×)] | |||
| m |
|
01:04 (cur | prev) +108 Jwarner talk contribs | |||
| N |
|
01:03 (cur | prev) +36 Jwarner talk contribs Created page with "Category:General reference pages" | |||
|
|
m 01:04 | NCCN guidelines 2 changes history +24 [Jwarner (2×)] | |||
| m |
|
01:04 (cur | prev) -8 Jwarner talk contribs →Fatigue | |||
| m |
|
01:02 (cur | prev) +32 Jwarner talk contribs | |||
|
|
m 01:03 | ESMO guidelines 2 changes history -21 [Jwarner (2×)] | |||
| m |
|
01:03 (cur | prev) -8 Jwarner talk contribs →Palliative care | |||
| m |
|
01:01 (cur | prev) -13 Jwarner talk contribs | |||
|
|
m 01:03 | ASCO guidelines 4 changes history +24 [Jwarner (4×)] | |||
| m |
|
01:03 (cur | prev) -8 Jwarner talk contribs | |||
| m |
|
01:00 (cur | prev) +2 Jwarner talk contribs →Pain | |||
| m |
|
01:00 (cur | prev) +2 Jwarner talk contribs | |||
| m |
|
01:00 (cur | prev) +28 Jwarner talk contribs | |||
| m 00:05 | Pyruvate kinase deficiency diffhist +634 Jwarner talk contribs | ||||
1 May 2024
| m 20:14 | Ovarian cancer diffhist +3 Jwarner talk contribs →Carboplatin, Pegylated liposomal doxorubicin, Bevacizumab {{#subobject:a38gbb|Regimen=1}} | ||||
| m 15:53 | Nasopharyngeal carcinoma diffhist +6 Jwarner talk contribs | ||||
| m 13:47 | Breast cancer diffhist -167 Jwarner talk contribs →AC-T {{#subobject:633n67|Regimen=1}} | ||||
| 13:20 | User creation log User account Tmangur talk contribs was created | ||||
30 April 2024
| m 22:56 | How I Treat diffhist +209 Jwarner talk contribs →Waldenström macroglobulinemia (WM) | ||||
| m 22:54 | Follicular lymphoma diffhist +751 Jwarner talk contribs →References | ||||
| m 19:46 | Breast cancer, HER2-positive diffhist +1,008 Jwarner talk contribs | ||||
|
|
17:35 | Multiple myeloma, relapsed-refractory 2 changes history +1,926 [Jwarner (2×)] | |||
|
|
17:35 (cur | prev) +1,912 Jwarner talk contribs →VTD {{#subobject:96881b|Regimen=1}} | ||||
| m |
|
17:27 (cur | prev) +14 Jwarner talk contribs →Regimen variant #2 {{#subobject:fc94h1|Variant=1}} | |||
|
|
m 13:11 | Soft tissue sarcoma 4 changes history +1,765 [Jwarner (4×)] | |||
| m |
|
13:11 (cur | prev) 0 Jwarner talk contribs →Doxorubicin monotherapy {{#subobject:826f82|Regimen=1}} | |||
| m |
|
13:07 (cur | prev) +1,701 Jwarner talk contribs →Doxorubicin monotherapy {{#subobject:826f82|Regimen=1}} | |||
| m |
|
12:58 (cur | prev) +44 Jwarner talk contribs →References | |||
| m |
|
11:33 (cur | prev) +20 Jwarner talk contribs →Cisplatin monotherapy {{#subobject:6e93fa|Regimen=1}} | |||
|
|
m 11:31 | Desmoid tumor 2 changes history +12 [Jwarner (2×)] | |||
| m |
|
11:31 (cur | prev) +19 Jwarner talk contribs | |||
| m |
|
11:29 (cur | prev) -7 Jwarner talk contribs →Nirogacestat monotherapy {{#subobject:f3agdc|Regimen=1}} | |||
|
|
m 11:27 | Breast cancer, triple negative 9 changes history +826 [Jwarner (9×)] | |||
| m |
|
11:27 (cur | prev) +86 Jwarner talk contribs | |||
| m |
|
11:05 (cur | prev) +2 Jwarner talk contribs →References | |||
| m |
|
11:04 (cur | prev) +25 Jwarner talk contribs →Carboplatin & Gemcitabine (GCb) {{#subobject:d46b34|Regimen=1}} | |||
| m |
|
11:03 (cur | prev) +2 Jwarner talk contribs →References | |||
| m |
|
11:02 (cur | prev) +2 Jwarner talk contribs →References | |||
| m |
|
11:01 (cur | prev) +44 Jwarner talk contribs →References | |||
| m |
|
11:00 (cur | prev) +46 Jwarner talk contribs →FEC-D {{#subobject:0cagj9|Regimen=1}} | |||
| m |
|
10:58 (cur | prev) +5 Jwarner talk contribs →Carboplatin & Docetaxel {{#subobject:82336a|Regimen=1}} | |||
| m |
|
10:56 (cur | prev) +614 Jwarner talk contribs →References | |||
29 April 2024
| m 23:39 | Breast cancer - null regimens diffhist +804 Jwarner talk contribs →Placebo | ||||
| m 23:33 | Tisotumab vedotin (Tivdak) diffhist +166 Jwarner talk contribs | ||||
| m 23:32 | Cervical cancer diffhist +551 Jwarner talk contribs →Advanced or metastatic disease, subsequent lines of therapy | ||||
| 01:29 | User creation log User account Marinus4555 talk contribs was created | ||||
28 April 2024
| m 23:38 | Lutetium Lu 177 dotatate (Lutathera) diffhist +264 Jwarner talk contribs →History of changes in FDA indication | ||||
| 21:59 | Low-grade glioma, pediatric diffhist +1,125 Jwarner talk contribs →Temozolomide monotherapy {{#subobject:7b66b|Regimen=1}} | ||||
| N 21:54 | Tovorafenib (Ojemda) diffhist +1,193 Jwarner talk contribs Created page with "==Mechanism of action== From the [https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tovorafenib NCI Drug Dictionary]: An orally available inhibitor of wild-type..." | ||||
| m 21:48 | Drug index diffhist +56 Jwarner talk contribs →T | ||||
|
|
m 12:28 | Upper tract urothelial carcinoma 2 changes history +1,619 [Jwarner (2×)] | |||
| m |
|
12:28 (cur | prev) +217 Jwarner talk contribs | |||
| m |
|
12:27 (cur | prev) +1,402 Jwarner talk contribs | |||